| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 09/29/2011 | CA2794003A1 Novel spiro imidazolones as glucagon receptor antagonists, compositions, and methods for their use |
| 09/29/2011 | CA2793949A1 Novel spiro imidazolone derivatives as glucagon receptor antagonists, compositions, and methods for their use |
| 09/29/2011 | CA2789778A1 Cyclopentyl - and cycloheptylpyrazoles as fxr modulators |
| 09/29/2011 | CA2789200A1 Pharmaceutically active disubstituted triazine derivatives |
| 09/28/2011 | EP2368890A1 Hepatitis C virus inhibitors |
| 09/28/2011 | EP2368882A1 Anti-infective pyrimidines and uses thereof |
| 09/28/2011 | EP2368876A1 Derivatives of aminoindanes, their preparation and their application in therapeutics |
| 09/28/2011 | EP2367826A1 Modulators of amyloid beta. |
| 09/28/2011 | EP2367817A1 Inhibitors of diacylglycerol acyltransferase |
| 09/28/2011 | EP2367816A1 Isatin derivatives for use as in vivo imaging agents |
| 09/28/2011 | EP2367815A1 Pyridazinone derivatives |
| 09/28/2011 | EP2367814A1 New compounds 578 |
| 09/28/2011 | EP2367800A2 New compounds |
| 09/28/2011 | EP2367799A1 New compounds |
| 09/28/2011 | EP1966161B1 Carboxamides for controlling undesired micro-organisms in plant protection |
| 09/28/2011 | EP1912972B1 Substituted imidazole compounds as ksp inhibitors |
| 09/28/2011 | EP1569918B1 Triazine compounds and their use in forming multidimensional libraries for affinity chromatography |
| 09/28/2011 | CN1795174B Novel substituted 3-sulfur indoles |
| 09/28/2011 | CN102203213A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 09/28/2011 | CN102203085A Processes for the preparation of crystalline forms of sunitinib malate |
| 09/28/2011 | CN102203083A Compounds and compositions as kinase inhibitors |
| 09/28/2011 | CN102203082A Melanocortin receptor modulators, process for preparing them and use thereof in human medicine and cosmetics |
| 09/28/2011 | CN102203081A Oxoazetidine derivatives, process for the preparation thereof and use thereof in human medicine and in cosmetics |
| 09/28/2011 | CN102203080A Heterocyclically substituted anilinopyrimidines as fungicides |
| 09/28/2011 | CN102203075A Bicyclic kinase inhibitors |
| 09/28/2011 | CN102203067A Hedgehog pathway modulators |
| 09/28/2011 | CN102203064A Novel benzamides, production thereof, and use thereof as medicaments |
| 09/28/2011 | CN102203061A Selective seprase inhibitors |
| 09/28/2011 | CN102203060A 3-(benzylamino)-pyrrolidine derivatives and their use as nk-3 receptor antagonists |
| 09/28/2011 | CN102203059A Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof |
| 09/28/2011 | CN102202737A Disubstituted phthalazine hedgehog pathway antagonists |
| 09/28/2011 | CN102201432A Organic light-emitting device and method of manufacturing the same |
| 09/28/2011 | CN102199147A Nitroimidazole derivative in therapy |
| 09/28/2011 | CN102199144A Benzimidazole derivatives |
| 09/28/2011 | CN102199119A Oxime ester photoinitiators |
| 09/28/2011 | CN101633637B 8-oxo-8H-acenaphtho[1,2-b]pyrrole derivative |
| 09/27/2011 | US8026373 1,2,3-triazole bound borane compounds, synthesis of, and use in reduction reactions |
| 09/27/2011 | US8026359 Fungicidal heterocyclic amines |
| 09/27/2011 | US8026256 Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor |
| 09/27/2011 | US8026248 4-[[4-[(2,6-dichloro-phenyl)methyl]-6-[[2-(1-pyrrolidinyl)ethyl]amino]-2-pyrimidinyl]amino]benzonitrile; 4-[[4-[(2,4,6-trimethylphenyl)amino]-2-pyrimidinyl]amino]benzamide, N1-oxide combined with another retrovirus inhibitor; viricides; treatment of AIDS |
| 09/27/2011 | US8026247 Bicyclic amides as kinase inhibitors |
| 09/27/2011 | US8026244 Thioxanthine derivatives and their use as inhibitors of MPO |
| 09/27/2011 | US8026243 [4,5′]Bipyrimidinyl-6,4′-diamine derivatives as protein kinase inhibitors |
| 09/27/2011 | US8026241 Vanilloid receptor ligands and their use in treatments |
| 09/27/2011 | US8026237 Pyrrole derivatives as pharmaceutical agents |
| 09/27/2011 | US8026233 P38 inhibitors and methods of use thereof |
| 09/27/2011 | CA2615611C Indazole derivatives |
| 09/27/2011 | CA2503646C Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors |
| 09/27/2011 | CA2487542C Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides |
| 09/27/2011 | CA2467683C 5-phenylpyrimidines, agents comprising the same, method for production and use thereof |
| 09/27/2011 | CA2457410C Compounds effecting glucokinase |
| 09/27/2011 | CA2440630C Metalloproteinase inhibitors |
| 09/27/2011 | CA2403790C A cell division inhibitor and a production method thereof |
| 09/27/2011 | CA2258728C Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
| 09/22/2011 | WO2011115943A1 A substituted pyrimidine as a prostaglandin d2 receptor antagonist |
| 09/22/2011 | WO2011115940A1 Substituted pyrimidines as prostaglandin d2 receptor antagonists |
| 09/22/2011 | WO2011115813A1 Lactam acetamides as calcium channel blockers |
| 09/22/2011 | WO2011115804A1 Sgc stimulators |
| 09/22/2011 | WO2011115725A2 Indazole compounds and their uses |
| 09/22/2011 | WO2011115613A1 A method for synthesizing beta-lactam compounds by decomposition of an alpha-diazo-beta-ketoamide using a fluorescent light source |
| 09/22/2011 | WO2011115246A1 Ebna1 function inhibitor |
| 09/22/2011 | WO2011115064A1 Cycloalkyl-substituted imidazole derivative |
| 09/22/2011 | WO2011114246A1 Process for the preparation of malic acid salt of sunitinib |
| 09/22/2011 | WO2011113988A1 New derivatives of propargylamine having neuroprotective capacity for the treatment of alzheimer's and parkinson's diseases |
| 09/22/2011 | WO2011113894A1 Pyridine and pyrazine derivative for the treatment of cf |
| 09/22/2011 | WO2011113351A1 [(4-methyl-2-propyl-n-methoxy-substituted phenylalkyl-1h-benzimidazol-6-formamide)-1-yl]-methyl biphenyl compounds and their preparation methods |
| 09/22/2011 | WO2011113309A1 Pyrimidine derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists |
| 09/22/2011 | WO2011060297A3 Oxygen scavengers, composition comprising the scavengers, and articles made from the compositions |
| 09/22/2011 | US20110230664 New dye compounds |
| 09/22/2011 | US20110230651 Benzenesulfonamide derivatives and pharmaceutical composition therof |
| 09/22/2011 | US20110230533 Imidazolidinedione derivatives as antimalarial agents, preparation thereof, and methods of use |
| 09/22/2011 | US20110230500 Inhibitors of Phosphoinositide Dependent Kinase 1 (PDK1) |
| 09/22/2011 | US20110230495 1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds |
| 09/22/2011 | US20110230494 Heteroaryl compounds and uses thereof |
| 09/22/2011 | US20110230492 7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 09/22/2011 | US20110230489 s-TRIAZINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME |
| 09/22/2011 | US20110230486 Modulators Of HEC1 Activity And Methods Therefor |
| 09/22/2011 | US20110230485 6-phenyl-pyrimidin-4-yl-(phenylamine or phenoxy) derivatives useful as modulators of nicotinic acetylcholine receptors |
| 09/22/2011 | US20110230481 Derivatives of tetrabromobenzimidazole, a process for the preparation thereof, a pharmaceutical composition comprising the same, a method of using the same, a method for modulating or regulating serine/threonine kinases, and serine/threonine kinases modulating agent |
| 09/22/2011 | US20110230478 4-Alkyl-substituted diaminopyrimidines |
| 09/22/2011 | US20110230445 Substituted Heteroaryls |
| 09/22/2011 | US20110230419 Iap binding compounds |
| 09/22/2011 | US20110229918 Method of Quantifying Transient Interactions Between Proteins |
| 09/22/2011 | US20110227057 Perylene compound and organic light emitting device using the compound |
| 09/22/2011 | US20110226993 Improved Optical Brightening Compositions for High Quality Ink Jet Printing |
| 09/22/2011 | CA2793392A1 Pyridine and pyrazine derivative for the treatment of cf |
| 09/22/2011 | CA2793359A1 Process for the preparation of malic acid salt of sunitinib |
| 09/22/2011 | CA2793324A1 A substituted pyrimidine as a prostaglandin d2 receptor antagonist |
| 09/22/2011 | CA2793223A1 Substituted pyrimidines as prostaglandin d2 receptor antagonists |
| 09/22/2011 | CA2791613A1 Indazole compounds and their uses |
| 09/22/2011 | CA2791505A1 Cycloalkyl-substituted imidazole derivative |
| 09/21/2011 | EP2366700A1 Pyrrolidine-thioxopyrimidinone/thiohydantoin organocatolysts |
| 09/21/2011 | EP2366695A1 A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent |
| 09/21/2011 | EP2365970A1 Pyridazinones and their use as btk inhibitors |
| 09/21/2011 | EP2365752A1 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities |
| 09/21/2011 | EP2215082B1 Phthalazine and pyrido[3,4-d]pyridazine compounds as h1 receptor antagonists |
| 09/21/2011 | EP2212283B1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 09/21/2011 | EP2212282B1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 09/21/2011 | EP2103610B1 Salts of imidazol-5-carboxylic acid derivatives, preparation methods and use thereof |
| 09/21/2011 | EP1988777B1 Pyrazoles for the treatment of obesity and other cns disorders |